Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?

Annals of Hematology

Volumn 88, Issue 4, 2009, Pages 341-345

  Altès, Albert ^a   Bach, Vanessa ^b   Ruiz, Angels ^a   Esteve, Anna ^a   Remacha, Angel F ^b   Sardà, M Pilar ^b   Felez, Jordi ^b   Baiget, Montserrat ^b  

^a Althaia   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Ferroportin; Genetic penetrance; Haemochromatosis; Iron metabolism; SLC 40A1

Indexed keywords

FERROPORTIN; HFE PROTEIN; PROTEIN SLC40A1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; IRON OVERLOAD; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; CATION TRANSPORT PROTEINS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER DISEASES; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN;

EID: 60749097763     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0590-9     Document Type: Article

References (29)

1. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769-1778 doi: 10.1056/NEJMoa041534
2. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ et al (2008) Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221-230 doi: 10.1056/NEJMoa073286
3. Altes A, Ruiz A, Barceló MJ, Remacha AF, Puig T, Maya AJ et al (2004) Prevalence of C282Y, H63D and S65C mutations of HFE gene in 1146 newborns from a region of Northern Spain. Genet Test 8:407-410 doi: 10.1089/gte.2004.8.407
4. Altes A, Ruiz A, Martinez C, Esteve A, Vela MD, Remacha AF et al (2007) The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients. Ann Hematol 86:831-835 doi: 10.1007/s00277-007-0336-0
5. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U et al (2001) Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 36:1108-1115 doi: 10.1080/ 003655201750422747
6. Barry M, Sherlock SA (1971) Measurements of liver-iron concentration in needle-biopsy specimens. Lancet 1:100-103 doi: 10.1016/ S0140-6736(71)90838-5
7. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845-A (C282Y) HFE hereditary haemochromatosis mutations in USA. Lancet 359:211-218 doi: 10.1016/S0140-6736(02)07447-0
8. Beutler E, Beutler L, Lee PL, Barton JC (2004) The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis 33:344-345 doi: 10.1016/j.bcmd.2004.06.006
9. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M et al (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14-15 doi: 10.1038/75534
10. De Domenico I, Ward DM, Kaplan J (2007) Hepcidin regulation: Ironing out the details. J Clin Invest 117:1755-1758 doi: 10.1172/JCI32701
11. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI et al (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18:2569-2578 doi: 10.1091/mbc.E07-01-0060
12. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408 doi: 10.1038/ng0896-399
13. Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C (2004) HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood 103:2835-2840 doi: 10.1182/blood-2003-10-3366
14. Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S et al (2004) The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 13:1913-1918 doi: 10.1093/hmg/ddh206
15. Le Gac G, Férec C (2005) The molecular genetics of haemochromatosis. Eur J Hum Genet 13:1172-1185 doi: 10.1038/ sj.ejhg.5201490
16. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E (2001) A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 27:783-802 doi: 10.1006/ bcmd.2001.0445
17. Livesey KJ, Wimhurst VL, Carter K, Worwood M, Cadet E, Rochette J et al (2004) The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J Med Genet 41:6-10 doi: 10.1136/jmg.2003.008805
18. Merryweather-Clarke A, Pointon JJ, Shearman JD, Robson KJH (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278
19. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A et al (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12:2241-2247 doi: 10.1093/hmg/ddg225
20. Milet J, Dehais V, Bourgain C, Jouanolle AM, Mosser A, Perrin M et al (2007) Common Variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am J Hum Genet 81:799-807 doi: 10.1086/520001
21. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S et al (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619-623
22. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463 doi: 10.1182/ blood-2002-10-3235
23. Papanikolaou G, Sauels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dubé MP et al (2004) Mutation in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77-82 doi: 10.1038/ng1274
24. Pietrangelo A (2004) Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350:2383-2397 doi: 10.1056/NEJMra031573
25. Pietrangelo A (2004) The ferroportin disease. Blood Cells Mol Diseases 32:131-138 doi: 10.1016/j.bcmd.2003.08.003
26. Roetto A, Papanikolau G, Politou M, Alberti F, Girelli D, Christakis J et al (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21-22 doi: 10.1038/ng1053
27. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R (1998) Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 29:725-728 doi: 10.1016/S0168-8278(98)80252-3
28. Waalen J, Nordestgaard BG, Beutler E (2005) The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 18:203-220 doi: 10.1016/ j.beha.2004.08.023
29. Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW (2002) Subramaniam VN. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100:692-694 doi: 10.1182/ blood.V100.2.692